Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T J Cook

Showing results (31-40 of 34) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 34 results.
Urology|August 11, 1998
Treatment with finasteride preserves usefulness of prostate-specific antigen in the detection of prostate cancer: results of a randomized, double-blind, placebo-controlled clinical trial. PLESS Study Group. Proscar Long-term Efficacy and Safety StudyG L Andriole, H A Guess, J I Epstein, et al.
Archives of Internal Medicine|October 14, 1996
Safety and tolerability of cholesterol lowering with simvastatin during 5 years in the Scandinavian Simvastatin Survival StudyT R Pedersen, K Berg, T J Cook, et al.
The American Journal of Cardiology|August 3, 2000
Follow-up study of patients randomized in the Scandinavian simvastatin survival study (4S) of cholesterol loweringT R Pedersen, L Wilhelmsen, O Faergeman, et al.
Circulation|May 12, 1998
Lipoprotein changes and reduction in the incidence of major coronary heart disease events in the Scandinavian Simvastatin Survival Study (4S)T R Pedersen, A G Olsson, O Faergeman, et al.
Pageof 4

Showing results (31-40 of 34) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 34 results.
Urology|August 11, 1998
Treatment with finasteride preserves usefulness of prostate-specific antigen in the detection of prostate cancer: results of a randomized, double-blind, placebo-controlled clinical trial. PLESS Study Group. Proscar Long-term Efficacy and Safety StudyG L Andriole, H A Guess, J I Epstein, et al.
Archives of Internal Medicine|October 14, 1996
Safety and tolerability of cholesterol lowering with simvastatin during 5 years in the Scandinavian Simvastatin Survival StudyT R Pedersen, K Berg, T J Cook, et al.
The American Journal of Cardiology|August 3, 2000
Follow-up study of patients randomized in the Scandinavian simvastatin survival study (4S) of cholesterol loweringT R Pedersen, L Wilhelmsen, O Faergeman, et al.
Circulation|May 12, 1998
Lipoprotein changes and reduction in the incidence of major coronary heart disease events in the Scandinavian Simvastatin Survival Study (4S)T R Pedersen, A G Olsson, O Faergeman, et al.
Pageof 4